Ignite Creation Date:
2025-12-24 @ 11:43 PM
Ignite Modification Date:
2026-02-18 @ 3:46 AM
Study NCT ID:
NCT06505551
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-17
First Post:
2024-07-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1/2 Study of Autologous SCG142 TCR T Cells in Patients With HPV16/52-positive Carcinoma
Sponsor:
SCG Cell Therapy Pte. Ltd.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | HPV-Related Squamous Cell Carcinoma | View |
| None | HPV-Related Cervical Squamous Cell Carcinoma | View |
| None | HPV-Related Vulvar Squamous Cell Carcinoma | View |
| None | HPV-Related Penile Squamous Cell Carcinoma | View |
| None | HPV-Related Vaginal Squamous Cell Carcinoma | View |
| None | HPV-Related Anal Squamous Cell Carcinoma | View |
| None | HPV-Related Head and Neck Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Human Papilloma Virus | View |
| None | HPV | View |
| None | Cervical Cancer | View |
| None | Head and Neck Cancer | View |
| None | Oropharyngeal Cancer | View |
| None | Vulvar Cancer | View |
| None | Vaginal Cancer | View |
| None | Penile Cancer | View |
| None | Anal Cancer | View |
| None | Anogenital Cancer | View |
| None | TCR T Cell | View |
| None | Cell therapy | View |
| None | T cell receptor T cell | View |